1. Aman, M. G., and Singh, N. N. (1986). A critical appraisal of recent drug research in mental retardation: The Coldwater studies.Journal of Mental Deficiency Research, 30: 203–216.
2. Aman, M. G., and Singh, N. N. (1988).Psychopharmacology of the Developmental Disabilities, Springer-Verlag, New York.
3. Briggs, R. (1989). Monitoring and evaluating psychotropic drug use for persons with mental retardation: A follow-up report.Am. J. Ment. Retard. 93: 633–639.
4. Briggs, R., Hamad, C., Garrard, S., and Wills, F. (1984). A model for evaluating psychoactive medication use with the mentally retarded. In Mulick, J., and Mallory, B. (eds.),Transitions in Mental Retardation: Advocacy, Technology, and Science, Ablex, Norwood, NJ, pp. 229–248.
5. Buck, J. A., and Sprague, R. L. (1989). Psychotropic medication of mentally retarded residents in community long-term care facilities.Am. J. Ment. Retard. 93: 618–623.